Serious infection is a concern for patients with psoriasis receiving biologic therapies. We assessed the risk of serious infections for biologics used to treat psoriasis by comparison with a cohort receiving non-biologic systemic thera...
Leggi tuttoWe read with great interest the letter by Rishpon and Colleagues on our paper titled "Uncovering the diagnostic dermoscopic features of flat melanomas located on the lower limbs"...
Leggi tuttoObjective: evaluate the association between CU and metabolic syndrome and its components in a large community?based medical database...
Leggi tuttoObjective: determine the risk of elevated lipid levels (hyperlipidemia/hypertriglyceridemia), hypertension, metabolic syndrome, polycystic ovarian syndrome, diabetes, nonalcoholic liver disease, and elevated liver enzyme levels in chil...
Leggi tuttoAim: review the efficacy of perioperative antibiotics in reducing the risk of surgical-site infections (SSIs) following excision of ulcerated skin cancers...
Leggi tuttoPrevalence of adult AD ranged from 2.1% to 4.9% across countries. Severe AD represented a small proportion of the overall AD population regardless of measure or region....
Leggi tuttoThe second article in this continuing medical education series describes the evidence supporting new treatment methods, among them Janus kinase inhibitors...
Leggi tuttoWhile the majority of cutaneous squamous cell carcinomas (cSCCs) can be treated surgically, the additional work-up and treatments indicated for high-risk cSCC remain undefined...
Leggi tuttoCutaneous squamous cell carcinoma (cSCC), a malignant proliferation of cutaneous epithelium, represents 20% to 50% of skin cancers...
Leggi tuttoA consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society o...
Leggi tuttoObjective: determine the impact of dupilumab on rates of skin and other infections in patients with moderate-to-severe AD...
Leggi tuttoPart one of this two-part continuing medical education series describes the epidemiology, clinical evaluation, prognosis, and recent advancements in the understanding of the pathogenesis of AA...
Leggi tuttoIn seguito all'identificazione del peptide antimicrobico LL37 responsabile dell'attivazione delle cellule plasmacitoidi, la psoriasi può essere finalmente definita come una malattia autoimmunitaria...
Leggi tuttoNuovi concetti patogenetici nella psoriasi, dall'immunità adattativa ai nuovi target terapeutici dell'immunità innata...
Leggi tuttoInterleuchina-22 e la popolazione linfocitaria Th17 rappresentano un nuovo pathway e probabilmente un nuovo target...
Leggi tuttoPrimo modello murino di psoriasi volgare e artropatica che delinea un patway patogenetico non T linfocita mediato in cui due chemochine regolate da Jun sono all'esordio della malattia...
Leggi tuttoUna breve review sui meccanismi patogenetici identificati negli ultimi anni per rendere più comprensibili ed accessbili le scoperte e i risultati futuri...
Leggi tutto